$QTTB 4 SEC Filings

Filed On	Filing
14 Oct 2026	Form 4: Morrison Jodie Pope, Director Sold 3,221 shares ($26.8K)
14 Oct 2026	Form 4: Violette Shelia M., Chief Scientific Officer Sold 917 shares ($7.63K)
14 Oct 2026	Form 4: Kalowski Lee, CFO and President Sold 1,301 shares ($10.8K)
27 Aug 2026	Form 4: Morrison Jodie Pope, Director Sold 9,845 shares ($163K)
27 Aug 2026	Form 4: Kalowski Lee, CFO and President Sold 3,972 shares ($65.8K)
27 Aug 2026	Form 4: Violette Shelia M., Chief Scientific Officer Sold 2,798 shares ($46.3K)
20 Jul 2026	Form 4: Violette Shelia M., Chief Scientific Officer Received 37,500 shares as a grant or award
20 Jul 2026	Form 4: Morrison Jodie Pope, Director Received 132,000 shares as a grant or award
20 Jul 2026	Form 4: Kalowski Lee, CFO and President Received 53,250 shares as a grant or award
02 Jul 2026	Form 4: Manke Isaac, Director Received 53,521 shares by exercise or conversion ($150K)
16 Jun 2026	Form 4: Laporte Kathleen, Director Granted 9,810 Stock Option (Right to Buy)
16 Jun 2026	Form 4: Iwicki Mark T, Director Granted 9,810 Stock Option (Right to Buy)
16 Jun 2026	Form 4: Manke Isaac, Director Granted 9,810 Stock Option (Right to Buy)
16 Jun 2026	Form 4: Tzianabos Arthur, Director Granted 9,810 Stock Option (Right to Buy)
16 Jun 2026	Form 4: Grayzel David S., Director Granted 9,810 Stock Option (Right to Buy)
16 Jun 2026	Form 4: Thistle Mary, Director Granted 9,810 Stock Option (Right to Buy)
16 Jun 2026	Form 4: Xu Diyong, Director Granted 9,810 Stock Option (Right to Buy)
16 Jun 2026	Form 4: Lundberg Sven Ante, Director Granted 9,810 Stock Option (Right to Buy)
01 Jun 2026	Form 4: Xu Diyong, Director Bought 1,875,000 shares ($15M)
01 Jun 2026	Form 4: Orbimed Advisors Llc, Director and 2 others Bought 1,875,000 shares ($15M)

Comments